Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease

W. J. Sandborn, E. V. Loftus

Research output: Contribution to journal › Comment/debate › peer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease'. Together they form a unique fingerprint.